Elecsys (R) proBNP immunoassay for the diagnosis of congestive heart failure. Horizon scanning prioritising summary.
Mundy, L, Merlin, T
Record ID 32006000602
English
Authors' results and conclusions:
There is limited level 1b evidence (diagnostic levels of evidence) on the Elecsys proBNP Immunoassay, however the potential uptake of the technology is high. It appears that this test may be a useful adjunct in the rapid diagnosis of heart failure, although with apparently low test specificity.
Authors' recommendations:
HealthPACT recommends that a Horizon Scanning report be conducted.
Details
Project Status:
Completed
Year Published:
2004
URL for published report:
Not Available
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Heart Failure
- Immunoassay
- Diagnosis
- Natriuretic Peptide, Brain
- Peptide Fragments
Contact
Organisation Name:
Adelaide Health Technology Assessment
Contact Address:
School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name:
ahta@adelaide.edu.au
Contact Email:
ahta@adelaide.edu.au
Copyright:
Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.